Nicolas Marincek

1.2k total citations · 1 hit paper
11 papers, 944 citations indexed

About

Nicolas Marincek is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Nicolas Marincek has authored 11 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Oncology and 7 papers in Neurology. Recurrent topics in Nicolas Marincek's work include Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (8 papers) and Neuroblastoma Research and Treatments (7 papers). Nicolas Marincek is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (8 papers) and Neuroblastoma Research and Treatments (7 papers). Nicolas Marincek collaborates with scholars based in Switzerland, United States and Canada. Nicolas Marincek's co-authors include Martin A. Walter, Matthias Briel, Jan Müller‐Brand, Philippe Brunner, Christoph Rochlitz, Christian Schindler, Helmut R. Mäcke, Helmut Rasch, Helmut R. Maëcke and Piotr Radojewski and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Journal of Nuclear Medicine.

In The Last Decade

Nicolas Marincek

11 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

2011 452 citations Philippe Brunner, Nicolas Marincek et al. Journal of Clinical Oncology profile →

Peers

Nicolas Marincek

EPIDE

ONCOL

NEURO

RNMI

EDM

Marianne E. Pavel Germany

Anna Sundlöv Sweden

Tilmann Schumacher Switzerland

Jan-Paul Esser Netherlands

Ina Binse Germany

Esther I. van Vliet Netherlands

Johanna Svensson Sweden

Geert Ensing Netherlands

Miklos Pless Switzerland

Gregory D. Espenan United States

Marianne E. Pavel Germany

Nicolas Marincek

564 ×0.7

EPIDE

470 ×0.7

ONCOL

369 ×0.7

NEURO

256 ×1.2

RNMI

44 ×0.6

EDM

Citations per year, relative to Nicolas Marincek Nicolas Marincek (= 1×) peers Marianne E. Pavel

Countries citing papers authored by Nicolas Marincek

Since Specialization

Citations

This map shows the geographic impact of Nicolas Marincek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Marincek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Marincek more than expected).

Fields of papers citing papers by Nicolas Marincek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Marincek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Marincek. The network helps show where Nicolas Marincek may publish in the future.

Co-authorship network of co-authors of Nicolas Marincek

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Marincek. A scholar is included among the top collaborators of Nicolas Marincek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Marincek. Nicolas Marincek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Radojewski, Piotr, Rebecca A. Dumont, Nicolas Marincek, et al.. (2016). Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors. Journal of Nuclear Medicine. 58(1). 97–102. 7 indexed citations

Taelman, Vincent, Piotr Radojewski, Nicolas Marincek, et al.. (2016). Upregulation of Key Molecules for Targeted Imaging and Therapy. Journal of Nuclear Medicine. 57(11). 1805–1810. 57 indexed citations

Brunner, Philippe, Katharina Glatz, Lukas Bubendorf, et al.. (2016). The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 44(3). 468–475. 54 indexed citations

Radojewski, Piotr, Rebecca A. Dumont, Nicolas Marincek, et al.. (2015). Towards tailored radiopeptide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 42(8). 1231–1237. 14 indexed citations

Marincek, Nicolas, Piotr Radojewski, Rebecca A. Dumont, et al.. (2015). Somatostatin Receptor–Targeted Radiopeptide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial. Journal of Nuclear Medicine. 56(2). 171–176. 65 indexed citations

Dumont, Rebecca A., Nicolas Marincek, Philippe Brunner, et al.. (2015). Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma.. PubMed. 5(1). 46–55. 27 indexed citations

Taelman, Vincent, et al.. (2014). Indium-111 labeled gold nanoparticles for in-vivo molecular targeting. Biomaterials. 35(25). 7050–7057. 39 indexed citations

Marincek, Nicolas, Philippe Brunner, Christian Schindler, et al.. (2013). Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study. Journal of Translational Medicine. 11(1). 17–17. 21 indexed citations

Marincek, Nicolas, Philippe Brunner, Michael Koller, et al.. (2013). Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 41(2). 214–222. 61 indexed citations

10.

Marincek, Nicolas, Philippe Brunner, Michael Koller, et al.. (2012). Cohort Study of Somatostatin-Based Radiopeptide Therapy With [⁹⁰Y-DOTA]-TOC Versus [⁹⁰Y-DOTA]-TOC Plus [¹⁷⁷Lu-DOTA]-TOC in Neuroendocrine Cancers. Journal of Clinical Oncology. 30(10). 1100–1106. 147 indexed citations

11.

Brunner, Philippe, Nicolas Marincek, Matthias Briel, et al.. (2011). Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers. Journal of Clinical Oncology. 29(17). 2416–2423. 452 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact